The Central Regulatory Role of USP15 in Health and Disease
14 Apr 2026
Knowledge Insight: The Central Regulatory Role of USP15 in Health and Disease
Published by ANT BIO PTE. LTD.
1. Core Concepts
USP15 is a 981‑amino acid deubiquitinase (DUB) within the ubiquitin‑specific protease (USP) family. It contains an N‑terminal coiled‑coil protein–interaction domain, a canonical catalytic triad (thumb–palm–finger fold), and a regulatory C‑terminal extension. USP15 hydrolyzes multiple ubiquitin chain types (K48, K63, K29) and acts as a master regulator of TGF‑β signaling, immune homeostasis, neuroprotection, and cancer progression.
[Image Position: USP15 Protein Domain Architecture and Functional Overview]
2. Research Frontiers
- Structural basis of USP15 substrate recognition and catalytic regulation
- Context‑dependent control of TGF‑β/SMAD signaling in cancer and development
- Immune modulation via NF‑κB, TCR signaling, and PD‑L1 stabilization
- Neuroprotective and neurodegenerative roles in Parkinson’s and Alzheimer’s diseases
- Next‑generation therapeutics: selective USP15 inhibitors, PROTACs, and targeted delivery
3. Research Significance
USP15 is a central signaling hub whose dysregulation drives cancer, immune disorders, and neurodegeneration. As a druggable DUB, it represents a high‑priority therapeutic target. Validated, highly specific research tools are essential to dissect USP15 function, validate disease mechanisms, and accelerate drug discovery.
4. Key Mechanisms & Research Applications
4.1 Structure and Enzymatic Properties
USP15 displays broad ubiquitin chain preference, with higher catalytic efficiency toward K63‑linked ubiquitin. Its activity is tightly controlled by:
- AKT‑mediated phosphorylation (Ser728)
- SIRT1‑dependent deacetylation
- Dynamic subcellular localization (cytoplasm, Golgi, nucleus, mitochondria)
4.2 Regulation of the TGF‑β Pathway
USP15 drives a positive feedback loop in TGF‑β signaling:
- Stabilizes TβRI by opposing SMAD7–SMURF2‑mediated degradation
- Promotes SMAD3/4 transcriptional activity
- Drives EMT, invasion, and immune evasion in cancer
- Amplified in glioblastoma, breast cancer, and colorectal cancer
4.3 Dual Immune Regulatory Function
- Innate immunity: Modulates NF‑κB via TRAF2/6 deubiquitination
- Adaptive immunity: Enhances TCR signaling and T‑cell activation
- Immune checkpoint: Stabilizes PD‑L1 to promote immune escape
- Inhibitors synergize with anti‑PD‑1 immunotherapy
4.4 Roles in Neurological Disorders
- Parkinson’s disease: Activates Parkin‑mediated mitophagy
- Alzheimer’s disease: Activates GSK‑3β to promote tau hyperphosphorylation
- Ischemic injury: Time‑dependent biphasic neuroprotective and pro‑inflammatory effects
4.5 Targeted Therapy Development
- Selective small‑molecule inhibitors (e.g., TD‑U15‑1, CC‑90009)
- USP15‑targeting PROTACs for durable degradation
- Challenges: on‑target toxicity, delivery, and predictive biomarkers
[Image Position: USP15 Signaling Pathways and Therapeutic Intervention Map]
5. Research Tools Empowered by ANT BIO PTE. LTD.
ANT BIO PTE. LTD. provides a full suite of USP15‑specific research reagents to enable mechanistic studies, drug screening, and disease validation.
Core Product Advantages
表格
| Core Product Advantages |
|---|
| High isoform specificity with minimal cross‑reactivity against other USPs |
| Excellent sensitivity validated for WB, IHC, IF, IP, and functional assays |
| Rigorous quality control ensuring superior batch consistency |
Key Application Scenarios
表格
| Suitable Application Scenarios |
|---|
| Quantify USP15 expression in cancer and neural tissues |
| Analyze subcellular translocation and stress‑dependent dynamics |
| Identify interacting proteins and substrates via co‑IP |
| Evaluate USP15 inhibitor potency and selectivity |
| Profile TGF‑β pathway activity and immune checkpoint regulation |
6. Brand Mission
ANT BIO PTE. LTD. is a premium provider of life science reagents, offering high‑performance antibodies, recombinant proteins, detection kits, and general laboratory reagents. We operate three specialized sub‑brands: Absin (general reagents & kits), Starter (antibodies), and UA (recombinant proteins), delivering integrated, reliable solutions to advance global research in deubiquitination, signal transduction, and targeted therapy.
7. Related Product List
表格
| Product Name | Catalog Number | Brand | Supported Applications |
|---|---|---|---|
| USP15 Recombinant Rabbit Monoclonal Antibody | S0Bxxxx | Starter (ANT BIO PTE. LTD.) | WB, IHC, IF, IP |
| USP15 Activity Assay Kit | S0Bxxxx | Absin (ANT BIO PTE. LTD.) | Fluorometric enzymatic detection |
| Recombinant Human USP15 Protein | S0Bxxxx | UA (ANT BIO PTE. LTD.) | In vitro assays, inhibitor screening |
Brand Promotion Copy
ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs
At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.
